GSN p.Phe101=
c.303C>T · rs373779982 · VCV1623200
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -3.3 | GERP -3.8 |
| Overall | ||
| CADD | 8.863 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0213% | 4,690 |
| East Asian | 0.00891% | 11,222 |
| South Asian | 0.0011% | 91,076 |
| European (non-Finnish) | 0.000763% | 131,113 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GSN
- Protein
- p.Phe101=
- Coding
- c.303C>T
- MANE Select
- NM_198252
- dbSNP
- rs373779982
- Type
- single nucleotide variant
- Location
- chr9:121303017 (GRCh38)
- Gene constraint
- LOEUF 0.788 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 89.76 · 65 PDB
- Residue 101
- a β-strand; the 'actin-severing' region
Disease context
Finnish type amyloidosis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor AGel amyloidosis (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
Similar variants
- GSN p.Asn160Lys Pathogenic ★★ same condition
- GSN p.Asp163Asn Pathogenic/Likely pathogenic ★★ same condition
- GSN p.Asp163Tyr Pathogenic/Likely pathogenic ★★ same condition
- GSN c.1762+2T>C Uncertain significance ★★ same condition
- GSN c.513+1G>A Uncertain significance ★★ same condition
- GSN c.753+1G>A Uncertain significance ★★ same condition
- GSN c.754-1G>T Uncertain significance ★★ same condition
- GSN c.-9-1981C>T Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gsn-p-phe101 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown